






























Cypress Capital Management LLC WY Increases Stake in Seagate Technology PLC (NASDAQ:STX) - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Seagate Technology PLC

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Seagate Technology PLC with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

Axalta Coating Systems Ltd (NASDAQ:AXTA) Expected to Earn Q4 2017 Earnings of $0.43 Per Share
GCP Applied Technologies (GCP) and Crh Plc (CRH) Head to Head Analysis
Enable Midstream Partners, LP (NYSE:ENBL) Major Shareholder Sells $64,000.00 in Stock
Head to Head Review: Dean Foods (DF) and SunOpta (STKL)
Analyzing Global Brass and Copper Holdings (BRSS) & Aqua Metals (AQMS)
Head to Head Analysis: Kraton Corporation (KRA) and Innospec (IOSP)
CommScope Holding Company, Inc. (COMM) Upgraded to “Hold” by Zacks Investment Research
J.C. Penney Company, Inc. Holding Company (JCP) PT Set at $6.00 by BMO Capital Markets
Canaccord Genuity Cuts Essential Energy Services Ltd (TSE:ESN) Price Target to C$0.70
Aerie Pharmaceuticals, Inc. (AERI) Stock Rating Lowered by Zacks Investment Research
Tesla Inc. (NASDAQ:TSLA) Upgraded by Vetr Inc. to Strong-Buy
ArcelorMittal (MT) Stock Rating Upgraded by Zacks Investment Research
Canadian National Railway Company (CNR) Given Consensus Rating of “Hold” by Analysts
Continental Resources, Inc. (CLR) Receives Consensus Recommendation of “Buy” from Analysts
Zurich Insurance Group Ltd. (ZURVY) Given Consensus Recommendation of “Hold” by Brokerages
Cypress Capital Management LLC WY Increases Stake in Seagate Technology PLC (NASDAQ:STX)
-$0.29 Earnings Per Share Expected for Benefitfocus, Inc. (BNFT) This Quarter
Brokerages Expect National Fuel Gas Company (NYSE:NFG) Will Post Quarterly Sales of $372.67 Million
Education Realty Trust Inc. (NYSE:EDR) Shares Sold by First Trust Advisors LP
State Board of Administration of Florida Retirement System Continues to Hold Stake in Ringcentral, Inc. (NYSE:RNG)







Cypress Capital Management LLC WY Increases Stake in Seagate Technology PLC (NASDAQ:STX)


					Posted by Joanna Charbonneau on Jul 21st, 2017 // No Comments




Cypress Capital Management LLC WY raised its position in  Seagate Technology PLC (NASDAQ:STX) by 50.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,645 shares of the data storage provider’s stock after buying an additional 3,565 shares during the period. Cypress Capital Management LLC WY’s holdings in Seagate Technology PLC were worth $419,000 as of its most recent SEC filing. 
A number of other hedge funds have also added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System raised its stake in  Seagate Technology PLC by 4.7% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 21,342 shares of the data storage provider’s stock valued at $815,000 after buying an additional 950 shares during the last quarter.  Dimensional Fund Advisors LP raised its stake in  Seagate Technology PLC by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,122,226 shares of the data storage provider’s stock valued at $42,835,000 after buying an additional 37,835 shares during the last quarter.  Allianz Asset Management AG raised its stake in  Seagate Technology PLC by 0.6% in the fourth quarter. Allianz Asset Management AG now owns 17,326 shares of the data storage provider’s stock valued at $661,000 after buying an additional 100 shares during the last quarter.  Renaissance Technologies LLC purchased a new stake in  Seagate Technology PLC during the fourth quarter valued at approximately $3,317,000.  Finally, Franklin Resources Inc. raised its stake in  Seagate Technology PLC by 4.6% in the fourth quarter. Franklin Resources Inc. now owns 16,984 shares of the data storage provider’s stock valued at $648,000 after buying an additional 743 shares during the last quarter. 86.60% of the stock is owned by institutional investors. 


 Get Seagate Technology PLC alerts:



Shares of Seagate Technology PLC (STX) traded up 0.292% on Friday, hitting $39.535. The stock had a trading volume of 1,320,568 shares. The stock has a market cap of $11.73 billion, a P/E ratio of 16.270 and a beta of 1.73. The firm has a 50 day moving average of $40.54 and a 200 day moving average of $43.52. Seagate Technology PLC has a 12 month low of $30.09 and a 12 month high of $50.96. 





Seagate Technology PLC (NASDAQ:STX) last announced its quarterly earnings data on Wednesday, April 26th. The data storage provider reported $1.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.06 by $0.04. Seagate Technology PLC had a return on equity of 79.83% and a net margin of 6.61%. The firm had revenue of $2.67 billion for the quarter, compared to analyst estimates of $2.71 billion. During the same quarter in the prior year, the company posted $0.22 earnings per share. Seagate Technology PLC’s quarterly revenue was up 3.0% on a year-over-year basis.  On average, equities analysts forecast that  Seagate Technology PLC will post $4.45 earnings per share for the current fiscal year. 
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 5th. Investors of record on Wednesday, June 21st were issued a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a yield of 6.39%. The ex-dividend date of this dividend  was Monday, June 19th. Seagate Technology PLC’s dividend payout ratio  is presently 103.70%. 
WARNING: “Cypress Capital Management LLC WY Increases Stake in Seagate Technology PLC (NASDAQ:STX)” was first  reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.chaffeybreeze.com/2017/07/21/cypress-capital-management-llc-wy-increases-stake-in-seagate-technology-plc-nasdaqstx.html. 
Several analysts have commented on STX shares. Needham & Company LLC increased their price target on shares of Seagate Technology PLC from $55.00 to $57.00 and gave the company a “strong-buy” rating in a research report on Thursday, April 27th. Jefferies Group LLC decreased their price target on shares of Seagate Technology PLC from $55.00 to $50.00 and set a “buy” rating for the company in a research report on Friday, April 28th. Cowen and Company  reissued a “market perform” rating and set a $45.00 price target (down from $46.00) on shares of Seagate Technology PLC in a research report on Wednesday, April 26th. Royal Bank Of Canada  reissued a “hold” rating and set a $45.00 price target on shares of Seagate Technology PLC in a research report on Friday, June 9th. Finally, Longbow Research raised shares of Seagate Technology PLC from a “neutral” rating to a “buy” rating and increased their price target for the company from $18.42 to $55.00 in a research report on Tuesday, April 11th. Three analysts have rated the stock with a sell rating, nineteen have assigned  a hold rating, eight have issued  a buy rating and two have assigned  a strong buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $43.48.
In related news, SVP Mark Re sold 9,607 shares of the company’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $43.47, for a total transaction of $417,616.29. Following the transaction, the senior vice president now owns 40,470 shares of the company’s stock, valued at $1,759,230.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Stephen J. Luczo sold 100,000 shares of the company’s stock in a transaction on Tuesday, April 25th. The stock was sold at an average price of $50.00, for a total value of $5,000,000.00. Following the transaction, the chief executive officer now directly owns 27,188 shares in the company, valued at approximately $1,359,400. The disclosure for this sale can be found here. Insiders have sold 116,456 shares of company stock worth $5,715,313 in the last ninety days. 1.50% of the stock is currently owned by corporate insiders. 
Seagate Technology PLC Company Profile
Seagate Technology public limited company is a provider of electronic data storage technology and solutions. The Company’s principal products are hard disk drives (HDDs). In addition to HDDs, it produces a range of electronic data storage products, including solid state hybrid drives, solid state drives, peripheral component interconnect express (PCIe) cards and serial advanced technology architecture (SATA) controllers.
Want to see what other hedge funds are holding STX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Seagate Technology PLC (NASDAQ:STX).







Receive News & Ratings for Seagate Technology PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seagate Technology PLC and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 






















































 




Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version












﻿




























Cypress Capital Management LLC WY Boosts Stake in Teradyne, Inc. (TER) - StockNewsTimes














































 















 



  
 
  





















Daily Ratings & News for Teradyne Inc.
        	Complete the form below to receive the latest headlines and analysts' recommendationsfor Teradyne Inc. with our free daily email newsletter:



 






Follow @StockNewTimes









Recent Posts

Q3 2017 EPS Estimates for HCA Holdings, Inc. Decreased by SunTrust Banks (HCA)
Huntington National Bank Has $517,000 Position in TotalFinaElf, S.A. (TOT)
Jefferies Group Weighs in on Radius Health, Inc.’s Q3 2017 Earnings (RDUS)
Boenning Scattergood Equities Analysts Increase Earnings Estimates for Peoples Bancorp Inc. (PEBO)
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Natural Grocers by Vitamin Cottage (NGVC) Share Price
Johnson Financial Group LLC Invests $590,000 in Ford Motor Company (F)
Campbell Soup Company (NYSE:CPB) Position Boosted by PGGM Investments
Greenleaf Trust Acquires 7,723 Shares of SK Telecom Co., Ltd. (SKM)
Perion Network (PERI) Receives Coverage Optimism Score of 0.26
Foamix Pharmaceuticals (NASDAQ:FOMX) Receiving Positive Press Coverage, Report Shows
Basf Se (BAS) Earns “Buy” Rating from DZ Bank AG
Tenaris S.A. (NYSE:TS) Cut to Hold at BidaskClub
Cambridge Advisors Inc. Has $163,000 Position in iShares Gold Trust(ETF) (IAU)
LyondellBasell Industries NV (LYB) Stake Reduced by First Midwest Bank Trust Division
12,850 Shares in Analog Devices, Inc. (ADI) Acquired by Deltec Asset Management LLC
Favorable Press Coverage Somewhat Unlikely to Impact FRONTEO (FTEO) Stock Price
First Midwest Bank Trust Division Acquires 120 Shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL)
CENTENNIAL RES (CDEV) Position Held by Deltec Asset Management LLC
Ulta Beauty Inc. (ULTA) Shares Sold by Tributary Capital Management LLC
Deltec Asset Management LLC Reduces Position in Diamondback Energy, Inc. (NASDAQ:FANG)



 


Cypress Capital Management LLC WY Boosts Stake in Teradyne, Inc. (TER)

					Posted by Shawn Bailey on Jul 21st, 2017 // No Comments 



Cypress Capital Management LLC WY boosted its stake in  Teradyne, Inc. (NYSE:TER) by 694.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,725 shares of the semiconductor company’s stock after buying an additional 9,375 shares during the period. Cypress Capital Management LLC WY’s holdings in Teradyne were worth $322,000 at the end of the most recent quarter. 
Several other hedge funds and other institutional investors have also recently modified their holdings of TER. Gilman Hill Asset Management LLC raised its position in shares of  Teradyne by 17.1% in the first quarter. Gilman Hill Asset Management LLC now owns 11,020 shares of the semiconductor company’s stock valued at $343,000 after buying an additional 1,610 shares during the last quarter.  Nationwide Fund Advisors raised its position in shares of  Teradyne by 16.2% in the first quarter. Nationwide Fund Advisors now owns 707,660 shares of the semiconductor company’s stock valued at $22,008,000 after buying an additional 98,422 shares during the last quarter.  James Investment Research Inc. purchased a new position in shares of  Teradyne during the first quarter valued at approximately $156,000.  Dalton Greiner Hartman Maher & Co. raised its position in shares of  Teradyne by 2.4% in the first quarter. Dalton Greiner Hartman Maher & Co. now owns 671,107 shares of the semiconductor company’s stock valued at $20,871,000 after buying an additional 15,843 shares during the last quarter.  Finally, Reliance Trust Co. of Delaware purchased a new position in shares of  Teradyne during the first quarter valued at approximately $276,000. Institutional investors own  93.55% of the company’s stock. 


 Get Teradyne Inc. alerts:



Shares of Teradyne, Inc. (NYSE TER) traded down 1.13% during mid-day trading on Friday, hitting $34.93. The company had a trading volume of 1,052,468 shares. The firm’s 50 day moving average is $32.94 and its 200-day moving average is $31.29. Teradyne, Inc. has a 12-month low of $19.43 and a 12-month high of $36.59. The firm’s market cap is $6.95 billion. 




Teradyne (NYSE:TER) last released its quarterly earnings data on Wednesday, April 26th. The semiconductor company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.06. Teradyne had a positive return on equity of 18.34% and a negative net margin of 0.46%. The company had revenue of $457 million for the quarter, compared to analyst estimates of $440.96 million. During the same period in the prior year, the company posted $0.31 EPS. The company’s revenue was up 6.0% compared to the same quarter last year.  On average, equities analysts expect that  Teradyne, Inc. will post $1.89 EPS for the current year. 
The firm also recently announced a quarterly dividend, which was paid on Friday, June 23rd. Stockholders of record on Thursday, June 1st were issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.79%. The ex-dividend date  was Tuesday, May 30th. Teradyne’s payout ratio is currently -699.83%. 
TRADEMARK VIOLATION NOTICE: “Cypress Capital Management LLC WY Boosts Stake in Teradyne, Inc. (TER)” was originally  reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://stocknewstimes.com/2017/07/21/cypress-capital-management-llc-wy-boosts-stake-in-teradyne-inc-ter.html. 
Several research analysts have recently commented on the company. Needham & Company LLC lifted their target price on Teradyne from $32.00 to $40.00 and gave the stock a “buy” rating in a research report on Friday, April 28th. ValuEngine upgraded Teradyne from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Zacks Investment Research lowered Teradyne from a “strong-buy” rating to a “hold” rating in a research report on Monday, June 5th. BidaskClub upgraded Teradyne from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, Cowen and Company lifted their target price on Teradyne from $35.00 to $41.00 and gave the stock an “outperform” rating in a research report on Thursday, April 27th. One investment analyst  has rated the stock with a sell rating, three have issued  a hold rating and thirteen have issued  a buy rating to the company’s stock. Teradyne currently has a consensus rating of “Buy” and a consensus target price of $31.71.
In other news, Director Mercedes Johnson sold 8,000 shares of the business’s stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $35.07, for a total value of $280,560.00. Following the transaction, the director now directly owns 14,773 shares of the company’s stock, valued at approximately $518,089.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel W. Christman sold 3,232 shares of the business’s stock in a transaction that occurred on Wednesday, May 10th. The stock was sold at an average price of $35.65, for a total value of $115,220.80. Following the completion of the transaction, the director now directly owns 30,163 shares in the company, valued at $1,075,310.95. The disclosure for this sale can be found here. Insiders sold a total of 20,467 shares of company stock worth $721,961 over the last three months. 0.62% of the stock is owned by company insiders. 
About Teradyne
Teradyne, Inc supplies automation equipment for test and industrial applications. The Company designs, develops, manufactures and sells automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in the consumer electronics, wireless, automotive, industrial, communications, and aerospace and defense industries.
Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NYSE:TER).







Receive News & Ratings for Teradyne Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 



 























Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website








 


 

 










































﻿






























Benjamin F. Edwards & Company Inc. Has $938,000 Stake in Abbott Laboratories (NYSE:ABT) - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Abbott Laboratories

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Abbott Laboratories with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

LLBH Private Wealth Management LLC Boosts Stake in Bank of America Corporation (BAC)
UBS Asset Management Americas Inc. Has $336,000 Stake in Brooks Automation, Inc. (NASDAQ:BRKS)
UBS Asset Management Americas Inc. Increases Position in Etsy, Inc. (ETSY)
Extreme Networks, Inc. (NASDAQ:EXTR) Shares Bought by UBS Asset Management Americas Inc.
UBS Asset Management Americas Inc. Boosts Stake in Amicus Therapeutics, Inc. (FOLD)
UBS Asset Management Americas Inc. Reduces Stake in The Andersons, Inc. (NASDAQ:ANDE)
Oracle Corporation (ORCL) Stake Maintained by Tesco Pension Investment Ltd
Bristol-Myers Squibb Company (NYSE:BMY) Stake Boosted by LS Investment Advisors LLC
Benjamin F. Edwards & Company Inc. Has $938,000 Stake in Abbott Laboratories (NYSE:ABT)
Zurcher Kantonalbank Zurich Cantonalbank Decreases Stake in Bristol-Myers Squibb Company (BMY)
Amgen Inc. (AMGN) Position Boosted by Dumont & Blake Investment Advisors LLC
Exact Sciences Corporation (EXAS) Reaches New 52-Week High on Better-Than-Expected Earnings
Ray Gerald L & Associates Ltd. Continues to Hold Stake in Altria Group (MO)
International Business Machines Corporation (IBM) Stake Decreased by Public Employees Retirement Association of Colorado
Bank of New York Mellon Corp Raises Stake in NeoPhotonics Corporation (NYSE:NPTN)
Bank of New York Mellon Corp Buys 19,992 Shares of The Trade Desk Inc. (NASDAQ:TTD)
Bank of New York Mellon Corp Boosts Position in Eros International PLC (NYSE:EROS)
Orchid Island Capital, Inc. (ORC) Position Boosted by Bank of New York Mellon Corp
Bank of New York Mellon Corp Buys 9,575 Shares of Pacific Ethanol Inc (PEIX)
Security Asset Management Sells 180 Shares of Philip Morris International Inc (PM)







Benjamin F. Edwards & Company Inc. Has $938,000 Stake in Abbott Laboratories (NYSE:ABT)


					Posted by Joanna Charbonneau on Jul 28th, 2017 // No Comments




Benjamin F. Edwards & Company Inc. increased its position in  Abbott Laboratories (NYSE:ABT) by 1.4% during the first quarter, Holdings Channel reports. The institutional investor  owned 21,132 shares of the healthcare product maker’s stock after buying an additional 284 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in Abbott Laboratories were worth $938,000 at the end of the most recent reporting period. 
Other institutional investors also recently modified their holdings of the company. Whittier Trust Co. boosted its position in shares of  Abbott Laboratories by 1.7% in the first quarter. Whittier Trust Co. now owns 401,048 shares of the healthcare product maker’s stock worth $17,807,000 after buying an additional 6,751 shares in the last quarter.  Marshwinds Advisory Co. boosted its position in shares of  Abbott Laboratories by 118.2% in the first quarter. Marshwinds Advisory Co. now owns 66,576 shares of the healthcare product maker’s stock worth $2,957,000 after buying an additional 36,069 shares in the last quarter.  Farmers & Merchants Investments Inc. boosted its position in shares of  Abbott Laboratories by 7.6% in the first quarter. Farmers & Merchants Investments Inc. now owns 103,815 shares of the healthcare product maker’s stock worth $4,610,000 after buying an additional 7,309 shares in the last quarter.  Miller Howard Investments Inc. NY boosted its position in shares of  Abbott Laboratories by 3.1% in the first quarter. Miller Howard Investments Inc. NY now owns 1,529,641 shares of the healthcare product maker’s stock worth $67,931,000 after buying an additional 46,118 shares in the last quarter.  Finally, Barings LLC boosted its position in shares of  Abbott Laboratories by 19.0% in the fourth quarter. Barings LLC now owns 62,526 shares of the healthcare product maker’s stock worth $2,402,000 after buying an additional 10,000 shares in the last quarter. 71.08% of the stock is currently owned by hedge funds and other institutional investors. 


 Get Abbott Laboratories alerts:



Shares of Abbott Laboratories (NYSE ABT) opened at 50.11 on Friday. Abbott Laboratories has a 52 week low of $37.38 and a 52 week high of $51.13. The company has a market cap of $86.95 billion, a PE ratio of 70.18 and a beta of 1.07. The company has a 50 day moving average price of $48.68 and a 200 day moving average price of $45.00. 





Abbott Laboratories (NYSE:ABT) last posted its quarterly earnings data on Thursday, July 20th. The healthcare product maker reported $0.62 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.60 by $0.02. The business had revenue of $6.64 billion during the quarter, compared to the consensus estimate of $6.63 billion. Abbott Laboratories had a return on equity of 15.53% and a net margin of 4.96%. Abbott Laboratories’s quarterly revenue was up 24.5% on a year-over-year basis. During the same period last year, the company earned $0.55 earnings per share.  On average, equities analysts expect that  Abbott Laboratories will post $2.49 earnings per share for the current year. 
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Friday, July 14th will be issued a dividend of $0.265 per share. The ex-dividend date of this dividend is Wednesday, July 12th. This represents a $1.06 dividend on an annualized basis and a dividend yield of 2.12%. Abbott Laboratories’s payout ratio is presently 149.30%. 
COPYRIGHT VIOLATION WARNING: “Benjamin F. Edwards & Company Inc. Has $938,000 Stake in Abbott Laboratories (NYSE:ABT)” was first  posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://www.chaffeybreeze.com/2017/07/28/benjamin-f-edwards-company-inc-has-938000-stake-in-abbott-laboratories-nyseabt.html. 
A number of equities analysts recently weighed in on ABT shares. Zacks Investment Research cut Abbott Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, April 10th. Wells Fargo & Company  reissued an “outperform” rating and issued a $54.00 price target (up previously from $47.50) on shares of Abbott Laboratories in a research note on Friday, June 30th. TheStreet raised Abbott Laboratories from a “c+” rating to a “b” rating in a research note on Monday, July 3rd. Barclays PLC  reissued an “overweight” rating and issued a $57.00 price target (up previously from $52.00) on shares of Abbott Laboratories in a research note on Saturday, July 22nd. Finally, BMO Capital Markets  reissued a “hold” rating and issued a $48.00 price target on shares of Abbott Laboratories in a research note on Tuesday, July 11th. Four equities research analysts have rated the stock with a hold rating, twelve have issued  a buy rating and one  has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $52.13.
In related news, insider Stephen R. Fussell sold 196,550 shares of the stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $46.00, for a total transaction of $9,041,300.00. Following the completion of the transaction, the insider now directly owns 221,488 shares in the company, valued at $10,188,448. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jared Watkin sold 552 shares of the stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $47.97, for a total value of $26,479.44. Following the transaction, the insider now owns 47,090 shares of the company’s stock, valued at $2,258,907.30. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 201,702 shares of company stock valued at $9,301,413. 0.76% of the stock is owned by corporate insiders. 
Abbott Laboratories Company Profile
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States.
Want to see what other hedge funds are holding ABT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abbott Laboratories (NYSE:ABT).







Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 













































Cypress Capital Management LLC/WY: Company Profile - Bloomberg



































































  









Feedback


























cypress capital management llc/wy
Private Company









Company Profile
Sector: Financials
Industry: Asset Management
Sub-Industry: Wealth Management
Cypress Capital Management, LLC of Wyoming operates as an investment advisory firm. The Company offers services to individuals, retirement accounts, foundations, corporations, trusts, and small businesses in the State of Wyoming.




Corporate Information
Address:

PO Box J
Sheridan, WY 82801
United States


Phone:
-


Fax:
-























From The Web











Key Executives


Stephanie Ann Wagner


Chief Compliance Officer




William Bernard Ebzery


Managing Member




Matthew McGregor Ebzery


Managing Member







Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data













































Cypress Capital Management LLC (WY) Buys iShares US Preferred Stock, Exxon Mobil, Whiting ... - Nasdaq.com

















































































Hot Topics:
ETFs |
Smart Portfolio |
Currencies |
Online Broker Center















Search










































Cypress Capital Management LLC (WY) Buys iShares US Preferred Stock, Exxon Mobil, Whiting ...


April 19, 2017, 06:38:02 PM EDT
By insider, GuruFocus









































Shutterstock photo


Cypress Capital Management LLC ( WY )WYWYNew Purchases: NRZ , MU , GDX , MTZ, CWST, ARI, ZION, UCBI, KBE, RUSHA,Added Positions:PFF, XOM, WLL, SM, EEP, STX, SCHD, OCLR, HD, DRD,Reduced Positions:NKE, GILD, CELG, SBUX, RAI, SCHG, STZ, ALK, SCHX, PM,Sold Out:CORE, CALM, KR, CERN, IDT, ABMD, OZRK, TTMI, VMC, ROCK,For the details of Cypress Capital Management LLC ( WY )'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Cypress+Capital+Management+LLC+%28WY%29These are the top 5 holdings of Cypress Capital Management LLC ( WY )Altria Group Inc ( MO ) - 138,268 shares, 12.33% of the total portfolio. Shares reduced by 2.57%Celgene Corp ( CELG ) - 49,706 shares, 7.72% of the total portfolio. Shares reduced by 20.04%Reynolds American Inc ( RAI ) - 95,395 shares, 7.58% of the total portfolio. Shares reduced by 16.74%First Interstate BancSystem Inc ( FIBK ) - 144,001 shares, 7.13% of the total portfolio.Apple Inc (AAPL) - 33,006 shares, 5.92% of the total portfolio. Shares reduced by 3.79%New Purchase: New Residential Investment Corp (NRZ)Cypress Capital Management LLC ( WY ) initiated holdings in New Residential Investment Corp. The purchase prices were between $15.15 and $17.15, with an estimated average price of $16.36. The stock is now traded at around $17.75. The impact to the portfolio due to this purchase was 0.73%. The holdings were 34,300 shares as of 2017-03-31.New Purchase: Micron Technology Inc (MU)Cypress Capital Management LLC ( WY ) initiated holdings in Micron Technology Inc. The purchase prices were between $21.71 and $28.97, with an estimated average price of $24.42. The stock is now traded at around $27.26. The impact to the portfolio due to this purchase was 0.62%. The holdings were 17,115 shares as of 2017-03-31.New Purchase: VanEck Vectors Gold Miners (GDX)Cypress Capital Management LLC ( WY ) initiated holdings in VanEck Vectors Gold Miners. The purchase prices were between $20.92 and $25.57, with an estimated average price of $23.21. The stock is now traded at around $23.39. The impact to the portfolio due to this purchase was 0.47%. The holdings were 16,475 shares as of 2017-03-31.New Purchase: MasTec Inc (MTZ)Cypress Capital Management LLC ( WY ) initiated holdings in MasTec Inc. The purchase prices were between $34.5 and $41.55, with an estimated average price of $38.26. The stock is now traded at around $42.95. The impact to the portfolio due to this purchase was 0.43%. The holdings were 8,580 shares as of 2017-03-31.New Purchase: Casella Waste Systems Inc (CWST)Cypress Capital Management LLC ( WY ) initiated holdings in Casella Waste Systems Inc. The purchase prices were between $11.2 and $14.11, with an estimated average price of $12.41. The stock is now traded at around $14.18. The impact to the portfolio due to this purchase was 0.36%. The holdings were 20,480 shares as of 2017-03-31.New Purchase: Apollo Commercial Real Estate Finance Inc (ARI)Cypress Capital Management LLC ( WY ) initiated holdings in Apollo Commercial Real Estate Finance Inc. The purchase prices were between $16.84 and $18.93, with an estimated average price of $17.76. The stock is now traded at around $18.80. The impact to the portfolio due to this purchase was 0.27%. The holdings were 11,500 shares as of 2017-03-31.Added: iShares US Preferred Stock (PFF)Cypress Capital Management LLC ( WY ) added to the holdings in iShares US Preferred Stock by 138.10%. The purchase prices were between $37.21 and $38.78, with an estimated average price of $38.22. The stock is now traded at around $38.80. The impact to the portfolio due to this purchase was 1.37%. The holdings were 49,085 shares as of 2017-03-31.Added: Exxon Mobil Corp (XOM)Cypress Capital Management LLC ( WY ) added to the holdings in Exxon Mobil Corp by 373.65%. The purchase prices were between $80.93 and $90.89, with an estimated average price of $83.54. The stock is now traded at around $80.49. The impact to the portfolio due to this purchase was 0.88%. The holdings were 10,965 shares as of 2017-03-31.Added: Whiting Petroleum Corp (WLL)Cypress Capital Management LLC ( WY ) added to the holdings in Whiting Petroleum Corp by 3660.00%. The purchase prices were between $8.22 and $13.1, with an estimated average price of $10.79. The stock is now traded at around $8.16. The impact to the portfolio due to this purchase was 0.87%. The holdings were 75,200 shares as of 2017-03-31.Added: Enbridge Energy Partners LP (EEP)Cypress Capital Management LLC ( WY ) added to the holdings in Enbridge Energy Partners LP by 3712.50%. The purchase prices were between $17.34 and $26, with an estimated average price of $20.24. The stock is now traded at around $17.89. The impact to the portfolio due to this purchase was 0.7%. The holdings were 30,500 shares as of 2017-03-31.Added: SM Energy Co (SM)Cypress Capital Management LLC ( WY ) added to the holdings in SM Energy Co by 193.25%. The purchase prices were between $20.75 and $36.08, with an estimated average price of $27.7. The stock is now traded at around $21.71. The impact to the portfolio due to this purchase was 0.7%. The holdings were 35,190 shares as of 2017-03-31.Added: Seagate Technology PLC (STX)Cypress Capital Management LLC ( WY ) added to the holdings in Seagate Technology PLC by 84.38%. The purchase prices were between $36.34 and $49.48, with an estimated average price of $44.38. The stock is now traded at around $48.56. The impact to the portfolio due to this purchase was 0.19%. The holdings were 7,080 shares as of 2017-03-31.Sold Out: Core-Mark Holding Co Inc (CORE)Cypress Capital Management LLC ( WY ) sold out the holdings in Core-Mark Holding Co Inc. The sale prices were between $30.38 and $43.02, with an estimated average price of $34.96.Sold Out: Cal-Maine Foods Inc (CALM)Cypress Capital Management LLC ( WY ) sold out the holdings in Cal-Maine Foods Inc. The sale prices were between $36.8 and $44.45, with an estimated average price of $40.02.Sold Out: The Kroger Co (KR)Cypress Capital Management LLC ( WY ) sold out the holdings in The Kroger Co. The sale prices were between $28.69 and $34.91, with an estimated average price of $31.95.Sold Out: Cerner Corp (CERN)Cypress Capital Management LLC ( WY ) sold out the holdings in Cerner Corp. The sale prices were between $47.55 and $59.29, with an estimated average price of $54.05.Sold Out: IDT Corp (IDT)Cypress Capital Management LLC ( WY ) sold out the holdings in IDT Corp. The sale prices were between $12.26 and $20.29, with an estimated average price of $17.39.Sold Out: Abiomed Inc (ABMD)Cypress Capital Management LLC ( WY ) sold out the holdings in Abiomed Inc. The sale prices were between $104.1 and $125.26, with an estimated average price of $115.92.WYPFF 15-Year Financial DataThe intrinsic value of PFFPeter Lynch Chart of PFFWYWYWYWYPremium MembersThis article first appeared on GuruFocus .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.











This article appears in:
Investing                           
                            
                                , Stocks





Referenced Symbols:

                                        WY
                                    
, 

                                        MO
                                    
, 

                                        CELG
                                    
, 

                                        RAI
                                    
, 

                                        FIBK
                                    












More from GuruFocus



Subscribe




Warren Buffett: I could make you 50% a year on $1 million
A Strategy Ben Graham Used for 30 Years
Are CEOs Buying?














Related Stocks Articles




Subscribe







Eagle Materials, Inc. Cements Another Record for Revenue Thanks to an Acquisition


						7/28/2017 06:37 AM
					



European Stocks Follow Asia Lower on Technology Rout, Amazon Earnings Miss


						7/28/2017 06:36 AM
					



How Ford Found a Tax Break to Offset a Profit Drop


						7/28/2017 06:14 AM
					














Contributor:GuruFocus
Stock Picks, Portfolios



Follow on:

























Most Popular




Highest Rated








Mitel To Acquire ShoreTel - Quick Facts
Sientra Completes Acquisition of Miramar Labs®
Seagate Technology PLC Q4 Profit Rises 174%
LedgerX gets U.S. approval for derivatives on digital currencies
U.S. Fines Frontier, American And Delta For Violating Consumer







Shareholders Approve Major Structural Change to Top Performing...
Yatra Attains Leadership Position in Corporate Travel With the...
Miller Heiman Group Selects CallidusCloud Datahug for Pipeline...
Tractor Supply Company Reports Second Quarter Results
Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon




View All Highest Rated






















Research Brokers before you trade



		Compare Online Brokers
	


Want to trade FX?



		Visit our Forex Broker Center 
	
















Find a Credit Card



                    Select a credit card product by:
                


 Card Type
 Credit Score
 Card Issuer



                    Select an offer:
                





0% APR Credit CardsAirline Credit CardsBalance Transfer Credit CardsBusiness Credit CardsCash Back Credit CardsCharge CardsCharge Cards for BusinessEMV Smart ChipsGas Cards & Auto RewardsHome Improvement Rewards Credit CardsInstant Approval Credit CardsLow Interest Credit CardsNo Annual Fee Credit CardsNo Foreign Transaction Fee Credit CardsPoints Rewards Credit CardsPrepaid & Debit CardsReward Credit CardsStudent Credit CardsTop 10 Best Credit Card Deals and Offers




Bad CreditCredit Quality AverageCredit Quality ExcellentCredit Quality FairCredit Quality GoodLimited or No Credit HistoryPersonal Loans




American ExpressAmerican Express Airline CardsAmerican Express Business CardsAmerican Express Cash Back Credit CardsAmerican Express Charge CardsBarclaycardCapital OneCapital One Cash BackCapital One Fair CreditCapital One MilesCapital One PointsCapital One Prepaid Credit CardsChaseCiti Credit CardsDiscoverDiscover CashbackDiscover MilesDiscover Student Credit CardsMasterCard Credit CardsU.S. BankUSAAUSAA SavingsVisa Credit Cards







Search





Data Provided by BankRate.com






Stocks

Referenced





WY








50%



Rate It





MO








91%



Rate It





CELG








95%



Rate It





FIBK








100%



Rate It































CLOSEX

Edit Favorites

Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.






Update

Clear List







CLOSEX
Customize your NASDAQ.com experience
Background Color Selector

Select the background color of your choice:





 Black
							





 Slate Gray
							






 Light Gray
							





 Gray Blue
							






Quote Search

Select a default target page for your quote search:



						 Real-Time

						 After Hours

						 Pre-Market
 News
					


						 Flash Quote

						 Summary Quote

						 Interactive Charts

						 Default Setting




					Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
					If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
					
					If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.
				





CLOSEX
Please confirm your selection:

					You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings?


YES
NO













CLOSEX


Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.





CLOSEX











































Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









﻿

























Abbott Laboratories (NYSE:ABT) Shares Sold by Nisa Investment Advisors LLC - BNB Daily





































 
















 

 













Daily Ratings & News for Abbott Laboratories
Complete the form below to receive the latest headlines and analysts' recommendationsfor Abbott Laboratories with our free daily email newsletter:



 




Follow @bnbdailynews





Recent Posts

Intel Corporation’s (INTC) Neutral Rating Reiterated at Credit Suisse Group
Ironwood Pharmaceuticals, Inc. (IRWD) Shares Sold by California Public Employees Retirement System
Nelnet, Inc. (NNI) Shares Sold by California Public Employees Retirement System
California Public Employees Retirement System Has $3.80 Million Position in ADTRAN, Inc. (ADTN)
Somewhat Favorable Press Coverage Very Unlikely to Impact Coach (COH) Stock Price
Versabank (VB) Insider Jean-Paul Martin Beker Purchases 4,465 Shares
Stanley Chia Sells 837 Shares of GrubHub Inc (GRUB) Stock
Teva Pharmaceutical Industries Limited (TEVA) Given Coverage Optimism Rating of 0.41
Zacks Investment Research Downgrades Martin Midstream Partners L.P. (MMLP) to Hold
Ingevity Corp (NGVT) Lifted to Buy at Zacks Investment Research
Macquarie Upgrades Matthews International Corporation (MATW) to “Outperform”
MRV Communications, Inc. (MRVC) Cut to “Market Perform” at Northland Securities
Autobytel Inc. (ABTL) Expected to Post Quarterly Sales of $35.55 Million
Carrefour Sa Spon (CRRFY) Given $5.40 Consensus Target Price by Analysts
Reading International Inc (RDI) Stock Rating Lowered by Zacks Investment Research
Whole Foods Market, Inc. (WFM) Upgraded to Buy by Vetr Inc.
Zacks Investment Research Lowers Intellipharmaceutics International Inc. (IPCI) to Sell
Primo Water Corporation (PRMW) Stock Rating Lowered by Zacks Investment Research
Zacks Investment Research Upgrades Glaukos Corporation (GKOS) to “Buy”
Cisco Systems, Inc. (CSCO) Rating Lowered to Hold at Vetr Inc.


 


Abbott Laboratories (NYSE:ABT) Shares Sold by Nisa Investment Advisors LLC

Posted by Renee Johnson on Jul 28th, 2017 // No Comments 

Nisa Investment Advisors LLC decreased its stake in Abbott Laboratories (NYSE:ABT) by 3.6% during the second quarter, according to its most recent filing with the SEC. The firm owned 662,273 shares of the healthcare product maker’s stock after selling 24,778 shares during the period. Nisa Investment Advisors LLC’s holdings in Abbott Laboratories were worth $31,824,000 at the end of the most recent reporting period. 
A number of other hedge funds have also recently modified their holdings of ABT. Cypress Capital Management LLC WY boosted its stake in shares of Abbott Laboratories by 37.9% in the first quarter. Cypress Capital Management LLC WY now owns 2,531 shares of the healthcare product maker’s stock valued at $112,000 after buying an additional 696 shares in the last quarter. Feltz Wealth PLAN Inc. bought a new stake in Abbott Laboratories during the first quarter valued at approximately $112,000. Advantage Investment Management LLC bought a new stake in Abbott Laboratories during the fourth quarter valued at approximately $120,000. First Command Financial Services Inc. boosted its stake in Abbott Laboratories by 10.2% in the first quarter. First Command Financial Services Inc. now owns 2,787 shares of the healthcare product maker’s stock valued at $124,000 after buying an additional 257 shares during the period. Finally, V Wealth Management LLC bought a new stake in Abbott Laboratories during the second quarter valued at approximately $127,000. 71.08% of the stock is currently owned by hedge funds and other institutional investors. 




Shares of Abbott Laboratories (NYSE ABT) opened at 50.11 on Friday. The firm has a market capitalization of $86.95 billion, a price-to-earnings ratio of 70.18 and a beta of 1.07. The firm has a 50-day moving average of $48.78 and a 200 day moving average of $45.04. Abbott Laboratories has a 12-month low of $37.38 and a 12-month high of $51.13. 


 Get Abbott Laboratories alerts:



Abbott Laboratories (NYSE:ABT) last announced its earnings results on Thursday, July 20th. The healthcare product maker reported $0.62 earnings per share for the quarter, beating analysts’ consensus estimates of $0.60 by $0.02. The business had revenue of $6.64 billion for the quarter, compared to the consensus estimate of $6.63 billion. Abbott Laboratories had a net margin of 4.96% and a return on equity of 15.53%. Abbott Laboratories’s quarterly revenue was up 24.5% on a year-over-year basis. During the same period last year, the firm posted $0.55 earnings per share. On average, equities research analysts expect that Abbott Laboratories will post $2.49 earnings per share for the current year. 
The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Friday, July 14th will be paid a $0.265 dividend. This represents a $1.06 dividend on an annualized basis and a yield of 2.12%. The ex-dividend date of this dividend is Wednesday, July 12th. Abbott Laboratories’s dividend payout ratio is currently 149.30%. 
TRADEMARK VIOLATION WARNING: This piece of content was first published by BNB Daily and is owned by of BNB Daily. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/07/28/abbott-laboratories-nyseabt-shares-sold-by-nisa-investment-advisors-llc.html. 
ABT has been the topic of several research analyst reports. Zacks Investment Research raised shares of Abbott Laboratories from a “sell” rating to a “hold” rating in a research note on Tuesday, April 4th. Cowen and Company reissued a “buy” rating and set a $48.00 price target on shares of Abbott Laboratories in a research note on Thursday, April 13th. Stifel Nicolaus reissued a “buy” rating and set a $49.00 price target on shares of Abbott Laboratories in a research note on Tuesday, April 18th. Jefferies Group LLC decreased their price target on shares of Abbott Laboratories from $52.00 to $50.00 and set a “buy” rating on the stock in a research note on Tuesday, April 18th. Finally, UBS AG reissued a “neutral” rating and set a $41.00 price target on shares of Abbott Laboratories in a research note on Tuesday, April 18th. Four equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $52.13.
In related news, insider Hubert L. Allen sold 4,600 shares of the firm’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $50.79, for a total value of $233,634.00. Following the sale, the insider now directly owns 105,479 shares of the company’s stock, valued at $5,357,278.41. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Stephen R. Fussell sold 196,550 shares of the firm’s stock in a transaction that occurred on Thursday, June 8th. The shares were sold at an average price of $46.00, for a total transaction of $9,041,300.00. Following the completion of the sale, the insider now directly owns 221,488 shares in the company, valued at $10,188,448. The disclosure for this sale can be found here. Insiders sold 201,702 shares of company stock worth $9,301,413 over the last ninety days. 0.76% of the stock is currently owned by insiders. 
Abbott Laboratories Company Profile
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. 
Want to see what other hedge funds are holding ABT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abbott Laboratories (NYSE:ABT).

 
Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.



 





















Latest News




Leave a Reply

Click here to cancel reply.




Name (Required) 



Mail (will not be published) (Required) 



Website






 










































Cypress Capital Management


















Cypress Capital Management



About UsOur PhilosophyOur AdvantageThe TeamHistoryOur ApproachPortfolio FundamentalsHow We Manage AssetsCostsPooled FundsOur ServicesPrivate ClientsInstitutional ClientsInvestor EducationTop 10 MistakesQuestioning an AdvisorReference MaterialQuarterliesContact Us 






"It will fluctuate... It will fluctuate"
The response that legendary financier J.P. Morgan is reported to have given when asked what the stock market is going to do.


Cypress Capital Management Ltd. was founded in 1998 with the goal of providing best-in-class, independent investment management services. Our clients include individuals, families, foundations and corporations, as well as pensions and other institutional investors. Our commitment to providing honest, professional and individually tailored service has allowed us to become one of the leading investment management firms in Western Canada.








Cypress 
Suite 1700 - 1055 West Georgia St.
PO Box 11136
Vancouver, B.C.
V6E 3P3 Canada


Phone: 604 659 1850
Fax: 604 659 1899
Toll Free: 1 877 659 1850
Email:
info@cypresscap.com






FATCA Disclosure
IRR vs TWRR Explained
Latest Disclosure
Terms & Conditions
About Us
Our Approach
Our Services
Investor Education
Contact Us


© Copyright 2017 | Cypress Capital Management | All Rights Reserved





﻿
































CA Inc. (CA) Position Raised by Carl Domino Inc - Markets Daily













































 
























 




 





















Daily Ratings & News for CA Inc.
        	Complete the form below to receive the latest headlines and analysts' recommendationsfor CA Inc. with our free daily email newsletter:



 





Follow @TheMarketsDaily


The Markets Daily









Recent Posts

Anglo American plc (LON:AAL) Stock Rating Reaffirmed by Investec
Ascential PLC (ASCL) Given New GBX 405 Price Target at Numis Securities Ltd
BidaskClub Downgrades Willdan Group, Inc. (NASDAQ:WLDN) to Buy
Whole Foods Market, Inc. (WFM) Downgraded by BidaskClub to “Sell”
Old Republic International Corporation (NYSE:ORI) Stake Increased by Breton Hill Capital Ltd.
CA Inc. (CA) Position Raised by Carl Domino Inc
Werner Enterprises, Inc. (NASDAQ:WERN) Upgraded at Bank of America Corporation
Mattel, Inc. (NASDAQ:MAT) Stake Lowered by Carl Domino Inc
Carl Domino Inc Has $414,000 Position in Carbonite, Inc. (CARB)
Carl Domino Inc Has $380,000 Position in E*TRADE Financial Corporation (NASDAQ:ETFC)
Carl Domino Inc Has $333,000 Position in Eagle Materials Inc (EXP)
Jag Capital Management LLC Boosts Stake in Alaska Air Group, Inc. (ALK)
TESARO, Inc. (NASDAQ:TSRO) Stake Lowered by Jag Capital Management LLC
Jag Capital Management LLC Purchases Shares of 118,457 Live Nation Entertainment, Inc. (NYSE:LYV)
Jag Capital Management LLC Buys 58,203 Shares of Cheniere Energy, Inc. (LNG)
Jag Capital Management LLC Acquires New Position in Monster Beverage Corporation (NASDAQ:MNST)
Breton Hill Capital Ltd. Sells 189,999 Shares of International Paper Company (IP)
Everest Re Group, Ltd. (NYSE:RE) Stake Lowered by Breton Hill Capital Ltd.
Chase Investment Counsel Corp Sells 181 Shares of NetApp, Inc. (NASDAQ:NTAP)
Chase Investment Counsel Corp Has $3.73 Million Position in Burlington Stores, Inc. (NYSE:BURL)




 


CA Inc. (CA) Position Raised by Carl Domino Inc

					Posted by Danessa Lincoln on Jul 26th, 2017 // No Comments 




Carl Domino Inc increased its stake in shares of  CA Inc. (NASDAQ:CA) by 1.0% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 33,596 shares of the technology company’s stock after buying an additional 340 shares during the period. Carl Domino Inc’s holdings in CA were worth $1,158,000 at the end of the most recent reporting period. 
Other hedge funds also recently made changes to their positions in the company. Parallel Advisors LLC increased its position in  CA by 3.4% in the first quarter. Parallel Advisors LLC now owns 3,245 shares of the technology company’s stock valued at $106,000 after buying an additional 107 shares during the period.  Acrospire Investment Management LLC increased its position in  CA by 280.0% in the first quarter. Acrospire Investment Management LLC now owns 3,800 shares of the technology company’s stock valued at $121,000 after buying an additional 2,800 shares during the period.  CENTRAL TRUST Co increased its position in  CA by 7.4% in the second quarter. CENTRAL TRUST Co now owns 4,609 shares of the technology company’s stock valued at $159,000 after buying an additional 319 shares during the period.  Tompkins Financial Corp increased its position in  CA by 294.7% in the first quarter. Tompkins Financial Corp now owns 5,387 shares of the technology company’s stock valued at $165,000 after buying an additional 4,022 shares during the period.  Finally, Hefty Wealth Partners increased its position in  CA by 5,080.4% in the first quarter. Hefty Wealth Partners now owns 5,284 shares of the technology company’s stock valued at $167,000 after buying an additional 5,182 shares during the period. Hedge funds and other institutional investors own  70.74% of the company’s stock. 


 Get CA Inc. alerts:



Shares of CA Inc. (CA) traded down 1.08% during midday trading on Wednesday, hitting $34.65. 579,386 shares of the stock were exchanged. The stock’s 50-day moving average price is $33.64 and its 200 day moving average price is $32.49. CA Inc. has a one year low of $30.01 and a one year high of $36.54. The stock has a market cap of $14.48 billion, a P/E ratio of 18.73 and a beta of 0.87. 




CA (NASDAQ:CA) last posted its quarterly earnings data on Thursday, May 11th. The technology company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.05. CA had a net margin of 19.20% and a return on equity of 17.15%. The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $996.59 million. During the same period in the prior year, the firm earned $0.60 earnings per share. The business’s quarterly revenue was up .3% on a year-over-year basis.  On average, analysts anticipate that  CA Inc. will post $2.38 earnings per share for the current year. 
TRADEMARK VIOLATION NOTICE: “CA Inc. (CA) Position Raised by Carl Domino Inc” was originally  reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.themarketsdaily.com/2017/07/26/ca-inc-ca-position-raised-by-carl-domino-inc.html. 
Several equities analysts have weighed in on CA shares. Citigroup Inc. raised their target price on shares of CA from $34.00 to $36.00 and gave the company a “neutral” rating in a report on Wednesday, June 28th. BidaskClub downgraded shares of CA from a “hold” rating to a “sell” rating in a report on Saturday, July 1st. Jefferies Group LLC  restated a “buy” rating and set a $38.00 target price on shares of CA in a report on Thursday, June 1st. DA Davidson  restated a “neutral” rating and set a $12.00 target price on shares of CA in a report on Friday, May 19th. Finally, FIG Partners upgraded shares of CA to an “outperform” rating and raised their target price for the company from $40.00 to $42.25 in a report on Wednesday, May 3rd. Four investment analysts have rated the stock with a sell rating, eight have assigned  a hold rating and five have given a buy rating to the company’s stock. CA  has an average rating of “Hold” and a consensus price target of $35.10.
In other CA news, insider Ayman Sayed sold 30,194 shares of the company’s stock in a transaction dated Wednesday, June 21st. The shares were sold at an average price of $35.62, for a total transaction of $1,075,510.28. Following the completion of the sale, the insider now directly owns 168,455 shares of the company’s stock, valued at $6,000,367.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.90% of the stock is currently owned by corporate insiders. 
About CA
CA, Inc (CA) is engaged in providing software solutions enabling customers to plan, develop, manage and secure applications and enterprise environments across distributed, cloud, mobile and mainframe platforms. The Company operates through three business segments: Mainframe Solutions, Enterprise Solutions and Services.







Receive News & Ratings for CA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 





























Latest News






Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website


























































